iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Tables)

Segment Reporting (Tables)

3 Months Ended

Sep. 30, 2015

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Geographic segments are components of an enterprise about which separate financial information is available and regularly evaluated by the chief operating decision maker in deciding how to allocate resources and in assessing performance.

			iBio
Three months ended September 30, 2015	iBio		Brazil		Total

Net revenues	$	160	$	-	$	160
Research and development expenses		551		-		551
General and administrative expenses		1,416		6		1,422
Operating loss		(1,807)		(6)		(1,813)

			iBio
Three months ended September 30, 2014	iBio		Brazil		Total

Net revenues	$	819	$	-	$	819
Research and development expenses		1,185		-		1,185
General and administrative expenses		1,029		21		1,050
Operating loss		(1,395)		(21)		(1,416)

			iBio
Total Assets for the Business Segments	iBio		Brazil		Total

September 30, 2015 (unaudited)	$	11,344	$	30	$	11,374
June 30, 2015		12,448		46		12,494